Services
Nanomerics has the in-house capability to develop delivery and formulation technologies from chemistry and physical-chemistry to pharmacokinteic or phamacodynamic evaluation.
Formulation Feasability
Development and Evaluation
In vitro - In vivo
We offer a broad range of bioanalytical services
Scale-up
From mg to kg
CSO Virpax Pharmaceuticals (USA)
“We partnered for 3 preclinical development projects – from delivery to the brain for treatment of CNS conditions to antiviral indications.
From the initial consultation to the final stages of preclinical development, Nanomerics provided insightful guidance and innovative solutions to any project bottlenecks, which was crucial in advancing our assets. Their team demonstrated unparalleled expertise and dedication, generating high-quality preclinical data for patent filings and
IND application packages.
We can confidently link our programs progress and positive path to first-in-human studies to Nanomerics' exceptional leadership and R&D capabilities.”
Executive Director N4 Pharma (UK)
Our partnership with Nanomerics has played a critical role in advancing our asset in oncology. The Nanomerics team streamlined our gene delivery platform through preclinical development
- from formulation work and in vitro screening in cells to in vivo evaluation in animal models. They expertly navigated through roadblocks and necessary optimisations at each step. Their work has allowed us to take further steps towards commercialisation.
We would recommend Nanomerics to any stakeholders in need of agile and competent R&D services to progress their assets through the preclinical development pipeline, especially in
oncology and gene delivery space.